ODDB.org: Open Drug Database | Drugs

Novartis Pharma Schweiz AG - Simbrinza, Brinzolamid 10mg/ml, Brimonidintartrat 2mg/ml, Augentropfensuspension

Swissmedic Registration	65186	Sequence	01
Product name	Simbrinza, Brinzolamid 10mg/ml	Description	Brimonidintartrat 2mg/ml, Augentropfensuspension
ATC-Classification	S01EC54	ATC-Description	Brinzolamide, Combinations
Introduction of Sequence	13.01.2015

Composition

brinzolamidum 10 mg, brimonidini tartras 2 mg, carbomerum 974P, natrii chloridum, mannitolum, propylenglycolum, tyloxapolum, acidum boricum, natrii hydroxidum aut acidum hydrochloridum ad pH, benzalkonii chloridum 0.03 mg, aqua purificata q.s. ad suspensionem pro 1 ml.

Packungsbestandteile

Galenic Form

Brimonidintartrat

Excipiens

Active Agent	Dose
Brimonidine Tartrate	2 mg/ml
Brinzolamide	10 mg/ml

BAG: Active Agent	Dose
Brimonidine Tartrate	2 mg
Brinzolamide	10 mg

Inactive agents	Dose
Boric Acid
Aqua Purificata
Benzalkonium Chloride	0.03 mg/ml
Carbomerum 974P
Mannitol
Sodium Chloride
Natrii Hydroxidum aut Acidum Hydrochloridum ad Ph
Propylenglycol
Tyloxapolum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	5 ml	16.63	34.50	B	SL	Yes
002	3 x 5 ml	47.39	67.95	B	SL	Yes

2025	©ywesee GmbH